Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 02 Apr 2025 for Intra-Cellular Therapies, Inc., €114.4M. Read the official filing
Filing timeline
BuySaleSharon Mates
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Sharon Mates: trading record in brief
All filings by Sharon Mates on record concern Intra-Cellular Therapies, Inc., in the capacity of chief executive. The record holds 26 filings, for trades running from 23 August 2021 to 2 April 2025.
Every open-market trade on record is a sale: 4 sales worth €5.1M. Other entries cover 3 share grants and 17 option exercises.
Most recently, on 2 April 2025, the filings show a transaction worth €114.4M in Intra-Cellular Therapies, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Sharon Mates
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations26 total
945,235 shares@ US$132.0092.8% of flowCommon StockSEC:0000950170-25-049595:0
190,000 shares0Common StockSEC:0000950170-25-047937:0
40,712 sharesCommon StockSEC:0000950170-25-036593:0
34,969 sharesCommon StockSEC:0000950170-25-032587:0
30,847 shares0Common StockSEC:0000950170-25-013765:0
51,000 shares@ US$12.730.5% of flowCommon StockSEC:0000950170-24-134240:0
35,604 shares@ US$12.730.3% of flowCommon StockSEC:0000950170-24-102475:0
22,713 shares@ US$17.570.3% of flowCommon StockSEC:0000950170-24-101506:0
53,013 shares@ US$17.570.7% of flowCommon StockSEC:0000950170-24-100275:0
8,638 shares@ US$16.860.1% of flowCommon StockSEC:0000950170-24-048467:0
31,958 shares@ US$66.381.6% of flowCommon StockSEC:0000950170-24-029583:0
40,712 sharesCommon StockSEC:0000950170-24-028822:0
22,590 sharesCommon StockSEC:0000950170-24-021568:0
33,885 shares0Common StockSEC:0000950170-24-011398:0
75,361 shares@ US$16.860.9% of flowCommon StockSEC:0000950170-24-005557:0
27,468 shares@ US$53.5541.1% of flowCommon StockSEC:0001209191-23-050101:0
41,770 shares0Common StockSEC:0001209191-23-018283:0
22,590 sharesCommon StockSEC:0001209191-23-013434:0
27,848 sharesCommon StockSEC:0001209191-23-011982:0
33,083 shares@ US$55.001.4% of flowCommon StockSEC:0001209191-22-061532:0
38,925 shares@ US$2.840.1% of flowCommon StockSEC:0001209191-22-017858:0
22,589 sharesCommon StockSEC:0001209191-22-013346:0
27,847 sharesCommon StockSEC:0001209191-22-012385:0
41,896 sharesCommon StockSEC:0001209191-22-002984:0
1,416 shares@ US$40.000.0% of flowCommon StockSEC:0001209191-21-060741:0
25 of 26 declarations
